The treatment of novel coronavirus pneumonia should be approached from two perspectives: 1) relevant treatment against the virus; 2) symptomatic treatment. If the patient has dyspnea and low oxygen, the relevant treatment can be carried out with a ventilator to increase the oxygen level. If the patient has electrolyte disorders, relevant rehydration methods and salt replenishment methods can be used for corresponding treatment. If the patient has fever, it can be treated with antipyretic methods, but this series of treatments are all symptomatic treatments, and the causative treatment is to treat the virus, and the only way to do this is vaccine treatment. Vaccine is to isolate the virus, then inactivate the virus, and inject the inactivated virus into the human body to make the human body produce relevant antibodies, so that the human body will be resistant to this kind of virus when infected by this kind of virus. Therefore, the vaccine treatment method is a true cause-specific treatment. At present, the treatment of the new coronavirus pneumonia is mainly symptomatic, because the vaccine has not yet been produced. 2003 SARS after the relevant research units of the SARS vaccine research and development, about three years to develop the vaccine, the vaccine to get a few steps, first of all, inactivated virus strains from the laboratory to make out, and after doing so, we must carry out the relevant tests on animals, animal testing, and then after the success of the animal test, the vaccine will be released to the public, and then the vaccine will be released. There are several steps to get a vaccine, first we have to make the inactivated virus strain from the laboratory, after that we have to conduct relevant tests on animals, after the animal tests are successful, then we have to conduct relevant tests on human beings, and after the tests, we can get a real product that can be used in the clinic before we can call it a medical vaccine, and the time is usually more than one year. Source: Dr. Yurai